All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
MIRA PHARMACEUTICALS, INC. Last Reported: 5/31/2024 Stock Symbol: MIRA

Business Address

1200 BRICKELL AVENUE
SUITE 1950 #1183
MIAMI , FL US 33131

Mailing Address

324 SOUTH HYDE PARK AVENUE, SUITE 350

TAMPA , FL US 33606
Phone Number: 813-369-5150 / State Incorporated: FL / Fiscal Year End 0 /0

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022
Cash and Cash Equivalents -- -- -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- --
Inventory -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- --
Total Current Assets $4,858,230.00 $6,071,147.00 $420,719.00 $494,405.00 -- --
Property Plant and Equipement -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- --
Goodwill -- -- -- -- -- --
Other Assets -- -- -- -- -- --
Total Assets $4,932,443.00 $9,018,212.00 $3,825,136.00 $858,074.00 -- --
Accounts Payable -- -- -- -- -- --
Accrued Liabilities -- -- -- -- -- --
Total Current Liabilities $558,097.00 $902,901.00 $2,628,517.00 $1,454,306.00 -- --
Long Term Debt -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- --
Accumulated Deficit $-21,285,062.00 $-15,497,684.00 $-11,909,868.00 $-9,302,719.00 -- --
Total Stockholders' Equity $4,400,000.00 $8,100,000.00 $1,200,000.00 $-600,000.00 -- --
Controlling Interest in Subsidiaries -- -- -- -- -- --
Total Liabilities and Equity $4,932,443.00 $9,018,212.00 $3,825,136.00 $858,074.00 -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022
Total Revenues -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- --
Gross Profit -- -- -- -- -- --
Research and Development $1,572,962.00 $1,015,252.00 -- -- $714,968.00 --
Selling, General, and Administrative -- -- -- -- -- --
Total Operating Expenses $8,526,049.00 $5,469,692.00 $970,220.00 -- $5,700,227.00 $3,891,849.00
Loss from Operations -- -- -- -- -- --
Loss Before Income Taxes -- -- -- -- -- --
Earnings Per Share Basic $-0.64 $-0.45 $-0.20 -- $-0.14 $-0.30
Weighted Average Shares Basic 18,566,158 13,639,197 13,313,000 -- 13,168,556 13,093,000
Earnings Per Share Diluted $-0.64 $-0.26 $-0.20 -- $-0.14 $-0.30
Weighted Average Shares Diluted 18,566,158 13,639,197 13,313,000 -- 13,168,556 13,093,000
Common Stock Shares Authorized 100,000,000 100,000,000 100,000,000 95,000,000 -- --
Common Stock Shares Outstanding 14,780,885 14,780,885 13,313,000 13,313,000 -- --
Common Stock Value $1,478.00 $1,478.00 $6,657.00 $6,657.00 -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 -- --
Payments Of Dividends Common Stock -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 5,000,000 -- --
Preferred Stock Shares Outstanding -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 -- --
Share Price -- -- -- -- -- --
Copyright 2024 PursePoor.com